Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Trial to Determine the Optimal Bupivacaine Dose for Initiation of Labor Epidural Pain Relief

NCT04814537 is registered in ClinicalTrials.gov with Brigham and Women's Hospital as lead sponsor.

NCT NCT04814537
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04814537 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Trial to Determine the Optimal Bupivacaine Dose for Initiation of Labor Epidural Pain Relief
Lead sponsor
Brigham and Women's Hospital
Phase
Phase 4
Overall status
Completed
Start date
February 25, 2021
Completion date
March 23, 2022
Enrollment
100 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

analgesia, labor pain